Anne Phillips, MD, has been Senior Vice President, Clinical, Medical & Regulatory Affairs for Novo Nordisk Inc. since March 2013. She leads an integrated team across drug development, clinical operations, medical, regulatory, health economics and outcomes research, and safety. Dr. Phillips plays a key role in advancing Novo Nordisk's diabetes, obesity and biopharmaceuticals clinical development pipelines and is responsible for the efficient development and delivery of compounds in clinical trials, including product lifecycle and in-licensed compounds.
Before joining Novo Nordisk in 2011, Dr. Phillips was Vice President of Clinical Development at GlaxoSmithKline, leading diverse global and regional clinical teams supporting cardiovascular, metabolic, and oncology medicines, as well as drug discovery and Biotec alliance creation and execution. While there, she provided clinical leadership and partnership in the management of one of the company’s largest medicines and formulated a deep level of understanding of the needs of both patients and healthcare professionals and drug safety.
As a part of her more than 25 years in healthcare experience, Dr. Phillips was also Associate Professor and Chief of Infectious Diseases at Wellesley Central Hospital at the University of Toronto.
Dr. Phillips is active in community service and has served on a multitude of boards. She has also been recognized for her efforts in the areas of education and health. Dr. Phillips received the Outstanding Teacher Award at Wellesley Central Hospital/St. Michael’s Hospital for undergraduate and postgraduate excellence in teaching. For her contribution in the areas of HIV and AIDS, she won a humanitarian award for sustained excellence from an African community and was awarded the Governor General Award for ‘Outstanding Young Canadian’.
She is a Fellow of The Royal College of Physicians and Surgeons of Canada and received her MD from the University of Toronto, and holds an Honors Bachelor of Sciences in zoology from the University of Western Ontario.